Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial (Q34640765)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q5233311)
(Q125216967)
(P304) 2097-2105
(P407) (Q1860)
(P433) 9579
(P478) 369
(P577) Friday, June 1, 2007
(P921) (Q5452194)
(Q213901)
(Q11085)
(Q808)
(P1433) (Q939416)
(P1476) "Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial" (language: en)
(P2093) Michael G Kaplitt
Andrew Feigin
Helen L Fitzsimons
Paul Mattis
Patricia A Lawlor
Ross J Bland
Deborah Young
Kristin Strybing
Matthew J During
(P2860) (Q34186665)
(Q29619095)
(Q36226708)
(Q48620414)
(Q45883058)
(Q35171033)
(Q29620416)
(Q36251519)
(Q34023413)
(Q35579828)
(Q45859700)
(Q42280576)
(Q45882831)
(Q34154186)
(Q80573882)
(Q35694166)
(Q23909232)
(Q33874473)
(Q42484087)
(Q36159178)
(Q39453972)
(Q49045185)
(Q43767019)
(Q43679905)
(Q34554855)
(Q48433139)
(Q48615565)
other details